EA200000977A1 - COMPOSITIONS PAROXETINE - Google Patents
COMPOSITIONS PAROXETINEInfo
- Publication number
- EA200000977A1 EA200000977A1 EA200000977A EA200000977A EA200000977A1 EA 200000977 A1 EA200000977 A1 EA 200000977A1 EA 200000977 A EA200000977 A EA 200000977A EA 200000977 A EA200000977 A EA 200000977A EA 200000977 A1 EA200000977 A1 EA 200000977A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- paroxetine
- compositions
- depression
- therapy
- carrier
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Настоящее изобретение относится к пароксетину, адсорбированному на носителе с получением свободнотекучего порошка, используемого для заполнения капсул или получения таблеток; и применению его в терапии для лечения депрессии.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to paroxetine adsorbed onto a carrier to produce a free flowing powder used for filling capsules or for preparing tablets; and its use in therapy for the treatment of depression. The international application was published along with an international search report.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9806312.6A GB9806312D0 (en) | 1998-03-24 | 1998-03-24 | Novel formulations |
PCT/GB1999/000922 WO1999048499A1 (en) | 1998-03-24 | 1999-03-24 | Paroxetine compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200000977A1 true EA200000977A1 (en) | 2001-02-26 |
EA003393B1 EA003393B1 (en) | 2003-04-24 |
Family
ID=10829181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200000977A EA003393B1 (en) | 1998-03-24 | 1999-03-24 | Paroxetine compositions |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1063993A1 (en) |
JP (1) | JP2002507569A (en) |
CN (1) | CN1125639C (en) |
AP (1) | AP2000001914A0 (en) |
AU (1) | AU754765B2 (en) |
BG (1) | BG104865A (en) |
BR (1) | BR9908991A (en) |
CA (1) | CA2324612A1 (en) |
EA (1) | EA003393B1 (en) |
GB (1) | GB9806312D0 (en) |
HU (1) | HUP0101326A3 (en) |
ID (1) | ID26485A (en) |
IL (1) | IL138478A0 (en) |
NO (1) | NO313404B1 (en) |
NZ (1) | NZ506893A (en) |
PL (1) | PL343095A1 (en) |
SK (1) | SK14102000A3 (en) |
TR (1) | TR200002750T2 (en) |
WO (1) | WO1999048499A1 (en) |
ZA (1) | ZA200005697B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9914600D0 (en) * | 1999-06-22 | 1999-08-25 | Smithkline Beecham Plc | Novel,process |
DK200100341A (en) * | 2001-03-02 | 2002-09-03 | Gea Farmaceutisk Fabrik As | Process for the preparation of pharmaceutical tablets containing paroxetine hydrochloride anhydrate |
CA2531097C (en) * | 2003-07-02 | 2012-10-09 | Abbott Laboratories | Process for preparing formulations of lipid-regulating drugs |
US8062664B2 (en) | 2003-11-12 | 2011-11-22 | Abbott Laboratories | Process for preparing formulations of lipid-regulating drugs |
HU1000278D0 (en) * | 2010-05-28 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | Novel pharmaceutical use uf silicic acid |
CN103961333B (en) * | 2014-05-07 | 2020-02-21 | 浙江华海药业股份有限公司 | Paroxetine mesylate capsule and preparation method thereof |
CN104027306A (en) * | 2014-06-25 | 2014-09-10 | 万特制药(海南)有限公司 | Paroxetine oral suspension and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
ES2058061T3 (en) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT. |
SK283608B6 (en) * | 1995-02-06 | 2003-10-07 | Smithkline Beecham Plc | New forms of parotexin hydrochloride |
CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
-
1998
- 1998-03-24 GB GBGB9806312.6A patent/GB9806312D0/en not_active Ceased
-
1999
- 1999-03-24 TR TR2000/02750T patent/TR200002750T2/en unknown
- 1999-03-24 BR BR9908991-2A patent/BR9908991A/en not_active IP Right Cessation
- 1999-03-24 NZ NZ506893A patent/NZ506893A/en unknown
- 1999-03-24 CA CA002324612A patent/CA2324612A1/en not_active Abandoned
- 1999-03-24 HU HU0101326A patent/HUP0101326A3/en unknown
- 1999-03-24 EA EA200000977A patent/EA003393B1/en not_active IP Right Cessation
- 1999-03-24 AP APAP/P/2000/001914A patent/AP2000001914A0/en unknown
- 1999-03-24 ID IDW20001883A patent/ID26485A/en unknown
- 1999-03-24 EP EP99911940A patent/EP1063993A1/en not_active Withdrawn
- 1999-03-24 CN CN99804347A patent/CN1125639C/en not_active Expired - Fee Related
- 1999-03-24 IL IL13847899A patent/IL138478A0/en unknown
- 1999-03-24 SK SK1410-2000A patent/SK14102000A3/en unknown
- 1999-03-24 WO PCT/GB1999/000922 patent/WO1999048499A1/en not_active Application Discontinuation
- 1999-03-24 PL PL99343095A patent/PL343095A1/en unknown
- 1999-03-24 JP JP2000537547A patent/JP2002507569A/en active Pending
- 1999-03-24 AU AU30451/99A patent/AU754765B2/en not_active Withdrawn - After Issue
-
2000
- 2000-09-22 NO NO20004740A patent/NO313404B1/en unknown
- 2000-10-16 BG BG104865A patent/BG104865A/en unknown
- 2000-10-16 ZA ZA200005697A patent/ZA200005697B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2324612A1 (en) | 1999-09-30 |
SK14102000A3 (en) | 2001-03-12 |
NO20004740D0 (en) | 2000-09-22 |
NO20004740L (en) | 2000-10-03 |
JP2002507569A (en) | 2002-03-12 |
EA003393B1 (en) | 2003-04-24 |
CN1294512A (en) | 2001-05-09 |
CN1125639C (en) | 2003-10-29 |
PL343095A1 (en) | 2001-07-30 |
ID26485A (en) | 2001-01-11 |
BG104865A (en) | 2001-05-31 |
NZ506893A (en) | 2003-06-30 |
TR200002750T2 (en) | 2000-12-21 |
GB9806312D0 (en) | 1998-05-20 |
AU754765B2 (en) | 2002-11-21 |
HUP0101326A3 (en) | 2002-06-28 |
BR9908991A (en) | 2000-12-12 |
AP2000001914A0 (en) | 2000-09-30 |
WO1999048499A1 (en) | 1999-09-30 |
IL138478A0 (en) | 2001-10-31 |
EP1063993A1 (en) | 2001-01-03 |
ZA200005697B (en) | 2001-10-02 |
HUP0101326A2 (en) | 2002-05-29 |
AU3045199A (en) | 1999-10-18 |
NO313404B1 (en) | 2002-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200000320A (en) | Novel compounds | |
SE9704544D0 (en) | Novel compounds | |
SE9704546D0 (en) | Novel compounds | |
NO20003698L (en) | Oral compositions | |
SE9904505D0 (en) | Novel compounds | |
HUP0100950A3 (en) | Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
BR0215281A (en) | Fused heterocyclic succinimide compounds and their analogues, modulators of nuclear hormone receptor function | |
PT1319007E (en) | FUSED HETEROCYCLIC SUCCINIMIDE COMPOUNDS AND ITS ANALOGS AS FUNCTION MODULATORS OF NUCLEAR HORMONAL RECEPTORS | |
MY136520A (en) | Novel compounds | |
EE02962B1 (en) | Mometasone furoate monohydrate, process for its preparation and pharmaceutical compositions | |
ATE433756T1 (en) | JELLILED COMPOSITIONS | |
DE60230920D1 (en) | CONDENSED CYCLIC MODULATORS OF THE FUNCTION OF NUCLEAR HORMONE RECEPTORS | |
SE9901875D0 (en) | Novel compounds | |
AU2002364082A8 (en) | Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function | |
EA200301275A1 (en) | CAPSULES FOR INHALATION | |
DK1578406T3 (en) | Modified Release Pharmaceutical Composition | |
EA200500388A1 (en) | METHOD OF OBTAINING DRY POWDER COMPOSITIONS FOR INHALATION | |
DE69034226D1 (en) | Preparation process of huperzine A and its analogs and compounds useful thereto | |
YU13301A (en) | Muscarinic agonists and antagonists | |
EA200000977A1 (en) | COMPOSITIONS PAROXETINE | |
YU59400A (en) | Azabicyclic 5ht1 receptor ligands | |
NO983177L (en) | Use of the 1-enantiomer of centroman for the preparation of a pharmaceutical composition for the treatment or prophylaxis of breast cancer | |
EE200200252A (en) | Use of Antibodies as Vaccines; Pharmaceutical Compositions Containing Antibodies; | |
DE69921486D1 (en) | DEXTRAN-LEPTIN CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS | |
EA200100098A1 (en) | SALT PAROXETINE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |